No results for ‘’
Norris Medicines Ltd
NSE: BSE: 524414
₹15.60
(0%)
Wed, 26 Aug 2026, 01:15 am
Market Cap (in Cr)0
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1990
- Norris Medicines Limited was established as a private limited company in the state of Maharashtra.
1991
- The company commenced commercial operations with the commissioning of the formulations unit.
1992
- The company launched its Ethical Division and was converted into a public limited company.
1994
- The company received a WHO cGMP certificate.
1995
- The company underwent major expansions.
1996
- The company started exporting to European, Middle East, Far East, and African countries.
2000
- The company issued 1,80,00,000 equity shares on a preferential/private placement basis to PHC Holdings Ltd. and Positive Healthcare (Asia) Ltd.
2006
- The company launched diabetic and cardiac products.
2007
- The company launched a dental product range.
2012
- The company launched a new molecule Tolperisone with Paracetamol tablet.
2013
- The company extended its anti-malarial range with Artemether Lumefantrine tablet and dry syrup.